Metagenomi, Inc. (MGX:NASDAQ) closed at $0.714 on November 12, 2026, down 5.59% on the day. The stock trades 61.8% below its 52-week high of $1.87 and 19.0% above its 52-week low of $0.600. Over the past year, it lost 59.0%. Metagenomi, Inc. is part of the Miscellaneous sector.
In 252 trading sessions since November 12, 2025, MGX closed higher on 102 days (40%). Its best day was December 3, 2025 (+13.83%) and its worst was November 12, 2025 (-15.45%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
At Metagenomi, we are creating potentially curative therapeutics using our metagenomics-powered genome editing toolbox.We believe tools with capabilities that go beyond the current technology landscape will be required in order to reach the full therapeutic potential of genome editing. By harnessing the power of metagenomics, the study of genomes recovered from uncultivated organisms in the natural environment, we are discovering and developing asuite of novel genome editing tools with the potential to make any desired therapeutic gene edit, anywhere in the human genome.
Find more stocks like MGX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.